NCT05085496
- Conditions
- Locally Advanced Skin Squamous Cell Carcinoma, Resectable Skin Squamous Cell Carcinoma, Unresectable Skin Squamous Cell Carcinoma
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Clinical trial condition
Resectable Skin Squamous Cell Carcinoma
Explore clinical trials studying Resectable Skin Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Resectable Skin Squamous Cell Carcinoma trial results
Active, Not Recruiting
A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer
NCT04315701
- Conditions
- Neoplasms, Neoplasms by Site, Recurrent Skin Squamous Cell Carcinoma, +7 more
- Locations
-
- Los Angeles County-USC Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- Hoag Memorial Hospital Newport Beach, California, United States
- Northwestern University Feinberg School of Medicine Chicago, Illinois, United States